Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Mignani

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Chemical Society Reviews|January 30, 2018
Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapyYong Hu, Serge Mignani, Jean-Pierre Majoral, et al.
Drug Discovery Today|January 9, 2022
Dendrimer nanoplatforms for veterinary medicine applications: A concise overviewSerge Mignani, Xiangyang Shi, João Rodrigues, et al.
Drug Discovery Today|September 17, 2015
Why and how have drug discovery strategies in pharma changed? What are the new mindsets?Serge Mignani, Scot Huber, Helena Tomás, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeuticsSerge Mignani, Xiangyang Shi, Maria Bryszewska, et al.
Pharmaceutics|September 28, 2021
Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An OpportunitySerge Mignani, Xiangyang Shi, Andrii Karpus, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 11, 2020
Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncologySerge Moffett, Tze Chieh Shiao, Leila Mousavifar, et al.
Drug Discovery Today|January 24, 2016
Compound high-quality criteria: a new vision to guide the development of drugs, current situationSerge Mignani, Scot Huber, Helena Tomás, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overviewDzmitry Shcharbin, Maria Bryszewska, Serge Mignani, et al.
Biomacromolecules|November 27, 2014
Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical reportSerge Mignani, Maria Bryszewska, Barbara Klajnert-Maculewicz, et al.
International Journal of Pharmaceutics|June 29, 2015
Phosphorus dendrimers and photodynamic therapy. Spectroscopic studies on two dendrimer-photosensitizer complexes: Cationic phosphorus dendrimer with rose bengal and anionic phosphorus dendrimer with methylene blueMonika Dabrzalska, Maria Zablocka, Serge Mignani, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Chemical Society Reviews|January 30, 2018
Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapyYong Hu, Serge Mignani, Jean-Pierre Majoral, et al.
Drug Discovery Today|January 9, 2022
Dendrimer nanoplatforms for veterinary medicine applications: A concise overviewSerge Mignani, Xiangyang Shi, João Rodrigues, et al.
Drug Discovery Today|September 17, 2015
Why and how have drug discovery strategies in pharma changed? What are the new mindsets?Serge Mignani, Scot Huber, Helena Tomás, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeuticsSerge Mignani, Xiangyang Shi, Maria Bryszewska, et al.
Pharmaceutics|September 28, 2021
Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An OpportunitySerge Mignani, Xiangyang Shi, Andrii Karpus, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 11, 2020
Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncologySerge Moffett, Tze Chieh Shiao, Leila Mousavifar, et al.
Drug Discovery Today|January 24, 2016
Compound high-quality criteria: a new vision to guide the development of drugs, current situationSerge Mignani, Scot Huber, Helena Tomás, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overviewDzmitry Shcharbin, Maria Bryszewska, Serge Mignani, et al.
Biomacromolecules|November 27, 2014
Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical reportSerge Mignani, Maria Bryszewska, Barbara Klajnert-Maculewicz, et al.
International Journal of Pharmaceutics|June 29, 2015
Phosphorus dendrimers and photodynamic therapy. Spectroscopic studies on two dendrimer-photosensitizer complexes: Cationic phosphorus dendrimer with rose bengal and anionic phosphorus dendrimer with methylene blueMonika Dabrzalska, Maria Zablocka, Serge Mignani, et al.
Pageof 12